Granada Biphasic Broth The product is a selective medium for the screening and identification of Streptococcus agalactiae in pregnant women using clinical specimens.
Published January 6, 2016 · Recall initiated: November 23, 2015
Summary
FDA records medical device Class II recall Z-0556-2016, published January 6, 2016 and initiated November 23, 2015. Recalling firm: Biomerieux Inc; Status: Terminated; Reported quantity: 24 cartons; Lot: REF 42722 - Lot Numbers 896, 897 & 899. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
FDA has determined that the product requires 510(k) clearance to continue marketing/distribution in the United States.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Biomerieux Inc
- Distributor
- US Distribution to states of: CA, GA, IN, MA, MN, MO, NY, OH and PA.
- Lot
- REF 42722 - Lot Numbers 896, 897 & 899
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAVITEK 2 AST-N461 TEST KIT, GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED, Reference Number 424811September 30, 2026
- FDAVITEK 2 AST-N447 TEST KIT Product reference 424620July 15, 2026
- FDAVITEK 2 Gram-negative Susceptibility Cards Containing o Polymyxin B (pb02n) o Ceftazidime/avibactam (cza02n) oFebruary 11, 2026
- FDAVITEK 2 - AST Test kits (in vitro diagnostic test cards for antimicrobial susceptibility): a) AST-N334, REFMay 1, 2024
- FDABarilla Packaged Specifically for FoodService, PENNE RIGATE, 160 OZ (10 LBS) (4.54 kg), GTIN 1007680839242,January 6, 2016
- FDAMOSAIQ Oncology Information System MOSAIQ is an oncology information system used to manage workflows forJanuary 6, 2016
Questions about this recall
Was Granada Biphasic Broth The product is a selective medium for the screening and identification of Streptococcus agalactiae in pregnant women using clinical specimens. recalled?
Yes. FDA published recall Z-0556-2016 on January 6, 2016. Reported hazard: FDA has determined that the product requires 510(k) clearance to continue marketing/distribution in the United States.
What should I do if I have this product?
Voluntary: Firm initiated · Letter